These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 14408715)
1. Treatment of chronic digestive dysfunctions with an entozyme compound tablet. KETY SS Am J Gastroenterol; 1960 Jan; 33():106-8. PubMed ID: 14408715 [No Abstract] [Full Text] [Related]
2. [Causal therapy of digestive disorders]. SCHWARZ G Hippokrates; 1960 Jan; 31():60-3. PubMed ID: 14444056 [No Abstract] [Full Text] [Related]
3. Anticholinergics in the therapy of disorders of the digestive tract. WISSMER B Rev Med Suisse Romande; 1959 Dec; 79():829-33. PubMed ID: 13845424 [No Abstract] [Full Text] [Related]
4. [Notes on Aludrox in digestive therapy]. FEVRIER P Lyon Med; 1962 Mar; 94():575-9. PubMed ID: 13892676 [No Abstract] [Full Text] [Related]
5. [Anticholinergic-meprobamate combination in the therapy of diseases of the digestive tract of psychosomatic nature]. ROTTINI E; MARRI G; CALANDRA P Minerva Med; 1962 Jun; 53():1756-60. PubMed ID: 14494481 [No Abstract] [Full Text] [Related]
6. SIEGEL L, GOLDBERG RI: A clinical evaluation of a new anticholinergic compound, glycopyrrolate. LAMPHIER TA Am J Gastroenterol; 1962 May; 37():551-5. PubMed ID: 14461852 [No Abstract] [Full Text] [Related]
7. [Clinical experiments with a new antispasmodic agent MTS 263 in gastroenterology and internal medicine]. DUBARRY JJ; TOURNERIE J; BERNARD JP; MARQUE J Gaz Med Fr; 1962 Feb; 69():485-7. PubMed ID: 13888018 [No Abstract] [Full Text] [Related]
8. [Therapeutic value in digestive pathology of a new synthetic substance: 1,1-diphenyl-3-hexamethylene-iminopropane HCl or hexadiphane, associated with dglucitol (sorbitol)]. GAUSSEN I Sem Hop Ther Paris; 1962 Jan; 38():32-3. PubMed ID: 13897304 [No Abstract] [Full Text] [Related]
9. [Apropos of the treatment of several patients with priamide in a department of internal pathology]. LANGERON L; VINCENT G; DUHAMEL M J Sci Med Lille; 1960 May; 78():298-305. PubMed ID: 14413966 [No Abstract] [Full Text] [Related]
10. [Anticholinergic agents]. MEEROFF M Prensa Med Argent; 1961 Apr; 48():1277-87. PubMed ID: 14472076 [No Abstract] [Full Text] [Related]
12. Studies on a new anticholinergic substance with marked antisecretory effect. STEIGMANN F; PAMUKCU F; CHUNG KS Am J Gastroenterol; 1960 Jan; 33():109-16. PubMed ID: 13834074 [No Abstract] [Full Text] [Related]
13. Maintenance therapy in gastrointestinal disorders; 18-month study of a new anticholinergic. HOFFMANN CR Am J Gastroenterol; 1959 Sep; 32():370-4. PubMed ID: 14402423 [No Abstract] [Full Text] [Related]
14. Evaluation of ambutonium bromide in the management of gastrointestinal disease. ROSSMAN M Am J Gastroenterol; 1960 Oct; 34():414-8. PubMed ID: 13743751 [No Abstract] [Full Text] [Related]
15. Librax in gastrointestinal disorders. BEER D Appl Ther; 1962 Mar; 4():253-7. PubMed ID: 13866519 [No Abstract] [Full Text] [Related]
16. Clinical test of a new tranquilizeranticholinergic combination in gastrointestinal disease. ADDLEMAN W Am J Gastroenterol; 1961 Dec; 36():678-82. PubMed ID: 13859381 [No Abstract] [Full Text] [Related]
17. A clinical evaluation of an anticholinergic agent in a sustained-release dose form. HOCK CW Curr Ther Res Clin Exp; 1962 Jul; 4():363-9. PubMed ID: 13907921 [No Abstract] [Full Text] [Related]
18. Treatment of dyspepsia with a combination of trifluoperazine and isopropamide iodide. PLATT ML Br J Clin Pract; 1960 Jun; 14():457-60. PubMed ID: 14433433 [No Abstract] [Full Text] [Related]